3 transcripts
CUE
Earnings call transcript
NASDAQ
2024 Q2
19 Aug 24
is progressing well. The investigators at Washington University are very close to completing enrollment in Schedule B, where patients are getting two
CUE
Earnings call transcript
NASDAQ
2023 Q4
8 Apr 24
of clinical activity, including multiple patients with stable disease observed across all 4 indications and the enthusiasm of the investigators
CUE
Earnings call transcript
NASDAQ
2023 Q2
9 Aug 23
screening enrollment rate continues to go exceedingly well, underscoring investigator enthusiasm in the need for effective therapies in WT1 expressing
- Prev
- 1
- Next